1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis B Vir (HBV) Revenue
1.4 Market by Type
1.4.1 Global Hepatitis B Vir (HBV) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Therapeutics
1.4.3 Vaccine
1.5 Market by Application
1.5.1 Global Hepatitis B Vir (HBV) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B Vir (HBV) Market Perspective (2015-2026)
2.2 Global Hepatitis B Vir (HBV) Growth Trends by Regions
2.2.1 Hepatitis B Vir (HBV) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis B Vir (HBV) Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis B Vir (HBV) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis B Vir (HBV) Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis B Vir (HBV) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Vir (HBV) Players by Market Size
3.1.1 Global Top Hepatitis B Vir (HBV) Players by Revenue (2015-2020)
3.1.2 Global Hepatitis B Vir (HBV) Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis B Vir (HBV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis B Vir (HBV) Market Concentration Ratio
3.2.1 Global Hepatitis B Vir (HBV) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis B Vir (HBV) Revenue in 2019
3.3 Hepatitis B Vir (HBV) Key Players Head office and Area Served
3.4 Key Players Hepatitis B Vir (HBV) Product Solution and Service
3.5 Date of Enter into Hepatitis B Vir (HBV) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis B Vir (HBV) Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis B Vir (HBV) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
5.2 Global Hepatitis B Vir (HBV) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hepatitis B Vir (HBV) Market Size (2015-2020)
6.2 Hepatitis B Vir (HBV) Key Players in North America (2019-2020)
6.3 North America Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
6.4 North America Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hepatitis B Vir (HBV) Market Size (2015-2020)
7.2 Hepatitis B Vir (HBV) Key Players in Europe (2019-2020)
7.3 Europe Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
7.4 Europe Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
8 China
8.1 China Hepatitis B Vir (HBV) Market Size (2015-2020)
8.2 Hepatitis B Vir (HBV) Key Players in China (2019-2020)
8.3 China Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
8.4 China Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hepatitis B Vir (HBV) Market Size (2015-2020)
9.2 Hepatitis B Vir (HBV) Key Players in Japan (2019-2020)
9.3 Japan Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
9.4 Japan Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hepatitis B Vir (HBV) Market Size (2015-2020)
10.2 Hepatitis B Vir (HBV) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
11 India
11.1 India Hepatitis B Vir (HBV) Market Size (2015-2020)
11.2 Hepatitis B Vir (HBV) Key Players in India (2019-2020)
11.3 India Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
11.4 India Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hepatitis B Vir (HBV) Market Size (2015-2020)
12.2 Hepatitis B Vir (HBV) Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Hepatitis B Vir (HBV) Introduction
13.1.4 Merck Revenue in Hepatitis B Vir (HBV) Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Details
13.2.2 Gilead Sciences Business Overview
13.2.3 Gilead Sciences Hepatitis B Vir (HBV) Introduction
13.2.4 Gilead Sciences Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.2.5 Gilead Sciences Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Hepatitis B Vir (HBV) Introduction
13.3.4 Novartis Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Hepatitis B Vir (HBV) Introduction
13.4.4 GlaxoSmithKline Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Hoffmann
13.5.1 Hoffmann Company Details
13.5.2 Hoffmann Business Overview
13.5.3 Hoffmann Hepatitis B Vir (HBV) Introduction
13.5.4 Hoffmann Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.5.5 Hoffmann Recent Development
13.6 La Roche
13.6.1 La Roche Company Details
13.6.2 La Roche Business Overview
13.6.3 La Roche Hepatitis B Vir (HBV) Introduction
13.6.4 La Roche Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.6.5 La Roche Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb Hepatitis B Vir (HBV) Introduction
13.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Merck、Gilead Sciences、Novartis、GlaxoSmithKline、Hoffmann、La Roche、Bristol-Myers Squibb
【免責事項】
https://www.globalresearch.jp/disclaimer